Business Wire

OH-PROCTER-&-GAMBLE

Share
P&G Studios and Harder Than You Think Foster Game Changing Conversations in New Podcast Series “Equal Too: Achieving Disability Equality”

Today, P&G Studios and the team at Harder Than You Think launch a new podcast series, “Equal Too: Achieving Disability Equality,” to shine a light on the biggest challenges faced by the disabled community and start a conversation about what is needed to drive equality. The podcast, hosted by UK television presenter and disability advocate Sophie Morgan, will focus on challenging perceptions, celebrating successes, and exploring how to transform the world for those who do and do not have a disability. Sophie will speak with some of the most informed and most famous professionals, influencers, and activists about key themes of disability and inclusion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210826005660/en/

“Equal Too” is a special six-part series featured on the podcast Seneca’s Conversations on Power and Purpose and is brought to you by the Seneca Women Podcast Network and iHeart Radio. The series will run through August and September and will explore thought-provoking topics, like:

  • The legacy of the Paralympic Movement and the lasting impact hosting the Paralympic Games has had on host cities and beyond
  • How legislation for disabled people is changing and what more needs to be done
  • The path of employment for disabled people 70 years after Sir Ludwig Guttmann began using sport to create space for disabled people in society

For “Equal Too,” the talented team behind the award-winning Netflix documentary Rising Phoenix have brought together an abundance of voices who are policymakers, activists, athletes, and allies from across the globe, including:

  • Jameela Jamil, actor and host recognized as an advocate for disability rights, LGBTQ+ rights, body neutrality, and her work as founder of the I Weigh Community
  • RJ Mitte, an American actor, advocate, and philanthropist who has been a global champion in speaking of his experiences with Cerebral Palsy in hopes of removing the stigma associated with disabilities
  • Tatyana McFadden, a Russian-American athlete who holds 17 Paralympic medals, whose efforts to advocate for disability equality led to the passage of several pieces of legislation to ensure students with disabilities have equal access to compete in athletics
  • Andrew Parsons, a Brazilian sports administrator, and the president of the International Paralympic Committee (IPC). The IPC and the International Disability Alliance recently spearheaded the launch of the #WeThe15 campaign, a global movement to represent the 1.2 billion people with disabilities in the world

“With ‘Equal Too’ bringing together so many powerful and influential voices, it will help us to work out where the Rising Phoenix story needs to go next,” said Greg Nugent, co-founder of Harder Than You Think and creator of Rising Phoenix . “The threads to the conversation are extraordinary and important and the need for the story to be told is more vital than ever.”

As the world turns its focus to the incredible athletes competing in the Paralympic Games and inspired by the recent launch of the IPC’s #WeThe15 initiative, the biggest disability equality movement of its kind, P&G is committing a $100,000 donation to the Agitos Foundation. This will help fuel the work of the IPC to change how young people perceive those with a disability.

“We believe that greater visibility is a critical step to changing perceptions on the journey to disability equality,” said Phil Duncan, P&G’s Chief Design Officer and Olympic Games Executive. “We all have more to learn, which is why it’s important for us to spotlight the hugely important conversations in ‘Equal Too.’ We are also proud to make a monetary donation to the Agitos Foundation, which is doing incredibly impactful work in raising long lasting awareness for the next generation.”

As meaningful conversations about inclusivity can only be made possible when equal voices are represented, “Equal Too” is made possible by a team – from producers to guests and contributors – comprised of more than 60% of people who identify as disabled. At the helm of the project are two influential women: host and executive producer Sophie Morgan and executive producer and story consultant Sinéad Burke. Sophie, who was paralyzed in a car crash when she was 18, is an award-winning broadcaster who has presented for Channel 4 at every Paralympic Games since the Paralympic Games London 2012 and is one of the first and only female, disabled television hosts in the world. Sinéad, the founder of accessibility consultancy, Tilting the Lens, is a little person who campaigns to raise the baseline standards of accessibility to build a world that is designed with disabled people, for the inclusion of all.

All episodes of the podcast will be released with downloadable transcripts available shortly thereafter. Additionally, they will be accompanied with captioned videos featuring a deaf British Sign Language signer, Rinkoo Barpaga. You can download and listen to “Equal Too,” part of Seneca's Conversations, on the iHeartradio App, Apple Podcasts, or whichever podcast player you use.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at www.pg.com/news .

About P&G Studios

P&G Studios develops and produces stories to help create positive change in society, often shining the light on under-represented voices and acts of good. Like-minded, mission-based creative innovators and innovative NGO organizations partner with P&G Studios to meet the growing demand for authentic stories that uplift and inspire. Recent programs include The Queen Collective and 8:46 films, the National Geographic ACTIVATE Series, The Tent Mender documentary series, TIME 100 Most Influential People of the Year and TIME Person of the Year one-hour specials, Coded short documentary, and the launch of the Seneca Women’s Podcast Network.

About Harder Than You Think

Harder Than You Think is an independent production company whose purpose is to help change the way we think using the power of the story. Harder Than You Think was created and co-founded by Greg Nugent and Godric Smith, formerly Directors of the London 2012 Olympics and Paralympics. Greg and Godric’s work includes the creation of the Heads Together Campaign for Their Royal Highnesses using film, which went on to transform the views of the nation on mental health, and the creation of The Earthshot Prize, which has become the most important award on the plant for action on the environment.

Rising Phoenix is a ten-year mission by Harder Than You Think that aims to change the way the world thinks about human potential. The project was born out of the success of Harder Than You Think's debut film ‘Rising Phoenix,’ a landmark and double Emmy winning feature documentary about the history of the Paralympic Movement released in 2020 on Netflix, and via further films and audio projects in development to tell the story of the next decade.

About Seneca Women

Co-founded by Ambassador Melanne Verveer, the first U.S. Ambassador for Global Women’s Issues, and Kim Azzarelli, a corporate, philanthropic and legal advisor, who together co-authored the best-selling book Fast Forward: How Women Can Achieve Power and Purpose, and joined by Sharon Bowen, former Commissioner of the U.S. Commodity Futures Trading Commission, Seneca Women has sought to accelerate women’s progress through signature thought leadership events at Davos, the Metropolitan Museum of Art and the New York Stock Exchange, as well as through the Seneca Women app, a weekly newsletter, and significant partnerships with the public and private sectors. The Seneca Women Podcast Network provides a platform for the voices of women as well as inspiring, purpose-driven and inclusive content.

About iHeartMedia

iHeartMedia (NASDAQ: IHRT) is the number one audio company in the United States, reaching nine out of 10 Americans every month – and with its quarter of a billion monthly listeners, has a greater reach than any other media company in the U.S. The company’s leadership position in audio extends across multiple platforms, including more than 850 live broadcast stations in over 160 markets nationwide; through its iHeartRadio digital service available across more than 250 platforms and 2,000 devices; through its influencers; social; branded iconic live music events; other digital products and newsletters; and podcasts as the #1 commercial podcast publisher. iHeartMedia also leads the audio industry in analytics, targeting and attribution for its marketing partners with its SmartAudio product, using data from its massive consumer base.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release

– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura

ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release

ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui

Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release

With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release

- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c

Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release

Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye